Sacroiliac Joint Fusion Industry Overview
The global sacroiliac joint fusion market size was valued at USD 539.30 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 19.0% from 2022 to 2030.
Growing technological developments, several minimally invasive surgical procedures, reimbursement coverage, and initiatives by key companies are some of the key drivers of this market. As per AmeriHealth Caritas by 2018, minimally invasive sacroiliac joint fusion was covered by Medicaid programs in 44 states in the U.S. while 32 Blue Cross Blue Shield plans covered minimally invasive joint fusion by 2019. This is anticipated to increase the number of MIS sacroiliac joint fusion procedures. The COVID-19 pandemic significantly impacted the market.
Gather more insights about the market drivers, restrains and growth of the Global Sacroiliac Joint Fusion Market
This included the canceled or deferred surgeries, low demand, supply chain challenges, delays in clinical trials, and low sales. The COVID-19 pandemic has brought about a series of changes. The impact triggered by the pandemic has been strong enough to increase the need for innovation in healthcare facilities. Virtual medical services appeared to be one of the most promising possibilities for orthopedic services worldwide. In the future, there will be more virtual healthcare systems. SI-BONE, a key player in the market, reported that its operations ran at suboptimal capacity due to decreased demand for its flagship iFuse product. This was owing to the global restrictions on elective procedures due to the COVID-19 pandemic, particularly during the Q2 of 2020.
The company also expensed certain labor and overhead costs, which affected its financial performance. As case volumes began to recover, SI-BONE witnessed a more normalized operations capacity during the second half of 2020. The company initially limited its clinical study expenses from mid-March through April 2020 due to the postponement of trials in hospitals. However, by May 2020 most hospitals allowed the resumption of clinical trials thus allowing the company to continue its RD activities during the pandemic. Technological advancements are also propelling the market growth.
The growing adoption of new materials and technologies for creating better and safer SI joint fusion systems is anticipated to fuel the market growth over the forecast period. This includes the use of additive manufacturing and 3D-printed titanium implants. The Siros Lateral Sacroiliac Joint Fusion system by Genesys Spine, for example, comprises 3D-printed implants that offer optimal stabilization. SI-BONE’s iFuse-3D implants consist of titanium plasma spray-coated 3D implants that mimic native cancellous bone and are based on self-harvesting technology. These additively manufactured and 3D-printed implants facilitate an interconnected “bone-like” surface that may improve osteointegration.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Additive Manufacturing Market - The global additive manufacturing market size was valued at USD 13.84 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 20.8% from 2022 to 2030. A total of 2.2 million units of 3D printers were shipped globally in 2021 and the unit shipments are expected to reach 21.5 million units by 2030.
- Clinical Trials Market - The global clinical trials market size was valued at USD 47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. However, the market growth was hindered in 2020 due to the COVID-19 pandemic. In 2020, Parexel and Synairgen plc formed a strategic collaboration for conducting a Phase III study of an Interferon-beta (IFN-beta) treatment for COVID-19 patients.
Sacroiliac Joint Fusion Market Segmentation
Grand View Research has segmented the global sacroiliac joint fusion market on the basis of indication, treatment type, end-user, and region:
Sacroiliac Joint Fusion Indication Outlook (Revenue, USD Million, 2017 - 2030)
- Degenerative Sacroiliitis
- Sacral Disruption
- Trauma
Sacroiliac Joint Fusion Treatment Type Outlook (Revenue, USD Million, 2017 - 2030)
- Surgery
- By Surgery Type
- MIS
- Open
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
Sacroiliac Joint Fusion End-user Outlook (Revenue, USD Million, 2017 - 2030)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others (Specialty Centers, Research Academic Institutes)
Sacroiliac Joint Fusion Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Market Share Insights
- October 2020: Orthofix received additional clearance from the FDA for its nanotechnology feature-NANOVATE to be used as part of its FIREBIRD system.
- June 2020: Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D-printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction.
Key Companies profiled:
Some prominent players in the global sacroiliac joint fusion market include
- SI-BONE, Inc.
- PainTEQ
- CornerLoc
- SIGNUS Medizintechnik GmbH
- Globus Medical
- Orthofix Medical Inc.
- Life Spine, Inc.
- Camber Spine Technologies, LLC
- CoreLink Surgical
- Xtant Medical
- Surgalign Spine Technologies, Inc.
- Medtronic
Order a free sample PDF of the Sacroiliac Joint Fusion Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
